These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32756227)

  • 1. Central Disorders of Hypersomnolence.
    Trotti LM
    Continuum (Minneap Minn); 2020 Aug; 26(4):890-907. PubMed ID: 32756227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline.
    Maski K; Trotti LM; Kotagal S; Robert Auger R; Rowley JA; Hashmi SD; Watson NF
    J Clin Sleep Med; 2021 Sep; 17(9):1881-1893. PubMed ID: 34743789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic Hypersomnia and Other Hypersomnia Syndromes.
    Trotti LM; Arnulf I
    Neurotherapeutics; 2021 Jan; 18(1):20-31. PubMed ID: 32901432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic hypersomnia and Kleine-Levin syndrome.
    Arnulf I; Dodet P; Leu-Semenescu S; Maranci JB
    Rev Neurol (Paris); 2023 Oct; 179(7):741-754. PubMed ID: 37684104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic Hypersomnia and Kleine-Levin Syndrome: Primary Disorders of Hypersomnolence Beyond Narcolepsy.
    Dye TJ
    Semin Pediatr Neurol; 2023 Dec; 48():101082. PubMed ID: 38065631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disorders of Excessive Daytime Sleepiness Including Narcolepsy and Idiopathic Hypersomnia.
    Berkowski JA; Shelgikar AV
    Sleep Med Clin; 2016 Sep; 11(3):365-78. PubMed ID: 27542882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solriamfetol for the treatment of excessive daytime sleepiness associated with narcolepsy.
    Yang J; Gao J
    Expert Rev Clin Pharmacol; 2019 Aug; 12(8):723-728. PubMed ID: 31215815
    [No Abstract]   [Full Text] [Related]  

  • 8. [Wake disorders. I. Primary wake disorders].
    Billiard M; Carlander B
    Rev Neurol (Paris); 1998 Feb; 154(2):111-29. PubMed ID: 9773032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central Disorders of Hypersomnolence.
    Blattner M; Maski K
    Continuum (Minneap Minn); 2023 Aug; 29(4):1045-1070. PubMed ID: 37590822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics and epigenetics of rare hypersomnia.
    Mogavero MP; DelRosso LM; Bruni O; Salemi M; Salsone M; Novellino F; Zucconi M; Ferini Strambi L; Ferri R
    Trends Genet; 2023 May; 39(5):415-429. PubMed ID: 36842900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitolisant, a wake-promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol.
    Krief S; Berrebi-Bertrand I; Nagmar I; Giret M; Belliard S; Perrin D; Uguen M; Robert P; Lecomte JM; Schwartz JC; Finance O; Ligneau X
    Pharmacol Res Perspect; 2021 Oct; 9(5):e00855. PubMed ID: 34423920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Narcolepsy and Other Central Hypersomnias.
    Dauvilliers Y; Barateau L
    Continuum (Minneap Minn); 2017 Aug; 23(4, Sleep Neurology):989-1004. PubMed ID: 28777172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solriamfetol: First Global Approval.
    Markham A
    Drugs; 2019 May; 79(7):785-790. PubMed ID: 31062265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic Management of Excessive Daytime Sleepiness.
    Ono T; Takenoshita S; Nishino S
    Sleep Med Clin; 2022 Sep; 17(3):485-503. PubMed ID: 36150809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Sleep Latency Test/Maintenance of Wakefulness Test and Central Hypersomnias: Evolving Diagnostic and Therapeutic Approaches.
    Sampat AC; Avidan AY
    J Clin Neurophysiol; 2023 Mar; 40(3):203-214. PubMed ID: 36872499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersomnolence, Hypersomnia, and Mood Disorders.
    Barateau L; Lopez R; Franchi JA; Dauvilliers Y
    Curr Psychiatry Rep; 2017 Feb; 19(2):13. PubMed ID: 28243864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia.
    Khan Z; Trotti LM
    Chest; 2015 Jul; 148(1):262-273. PubMed ID: 26149554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Excessive Daytime Sleepiness in Patients with Narcolepsy.
    Pérez-Carbonell L
    Curr Treat Options Neurol; 2019 Nov; 21(11):57. PubMed ID: 31713736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Narcolepsy and Other 'Central Disorders of Hypersomnolence'].
    Mathis J
    Praxis (Bern 1994); 2018; 107(21):1161-1167. PubMed ID: 30326812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comprehensive Review of Solriamfetol to Treat Excessive Daytime Sleepiness.
    Fuller MC; Carlson S; Pysick H; Berry V; Tondryk A; Swartz H; Cornett EM; Kaye AM; Viswanath O; Urits I; Kaye AD
    Psychopharmacol Bull; 2024 Mar; 54(1):65-86. PubMed ID: 38449471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.